You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ETBX-051

Showing 1 - 25 of 43
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Colorectal Cancer Metastatic, mCRC Trial in El Segundo (biological, drug, procedure)

Active, not recruiting
  • Colorectal Cancer Metastatic
  • mCRC
  • Aldoxorubicin Hydrochloride
  • +19 more
  • El Segundo, California
    Chan Soon-Shiong Institute for Medicine
Mar 28, 2022

Triple Negative Breast Cancer (TNBC) Trial in El Segundo (Leucovorin, 5-Fluorouracil, Aldoxorubicin HCl)

Withdrawn
  • Triple Negative Breast Cancer (TNBC)
  • El Segundo, California
    Chan Soon-Shiong Institute for Medicine
Mar 28, 2022

Non Small Cell Lung Cancer Trial in El Segundo (Nab-paclitaxel, Cisplatin, 5Fluorouracil)

Withdrawn
  • Non Small Cell Lung Cancer
  • El Segundo, California
    Chan Soon-Shiong Institute for Medicine
Mar 28, 2022

Triple Negative Breast Cancer Trial in El Segundo (drug, biological, procedure)

Active, not recruiting
  • Triple Negative Breast Cancer
  • Aldoxorubicin HCl
  • +17 more
  • El Segundo, California
    Chan Soon-Shiong Institute for Medicine
Mar 28, 2022

Prostatic Tumors, Prostatic Cancer Trial run by the NCI (ETBX-071; adenoviral PSA vaccine, ETBX-061; adenoviral MUC1 vaccine,

Completed
Has Results
  • Prostatic Neoplasms
  • Prostatic Cancer
  • ETBX-071; adenoviral PSA vaccine
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Apr 28, 2021

Ovarian Cancer Trial (biological, drug, radiation)

Withdrawn
  • Ovarian Cancer
  • Avelumab
  • +17 more
  • (no location specified)
Mar 17, 2021

Colorectal Cancer Trial (biological, drug, radiation)

Withdrawn
  • Colorectal Cancer
  • avelumab
  • +21 more
  • (no location specified)
Mar 17, 2021

Metastatic Pancreatic Cancer Trial in El Segundo (Gemcitabine, Nab-paclitaxel, Aldoxorubicin HCl)

Withdrawn
  • Metastatic Pancreatic Cancer
  • El Segundo, California
    Chan Soon-Shiong Institute for Medicine
Mar 17, 2021

Triple Negative Breast Cancer Trial (biological, drug, radiation)

Withdrawn
  • Triple Negative Breast Cancer
  • avelumab
  • +17 more
  • (no location specified)
Mar 17, 2021

Melanoma Trial (biological, drug, radiation)

Withdrawn
  • Melanoma
  • Avelumab
  • +17 more
  • (no location specified)
Mar 17, 2021

Hepatocellular Carcinoma Non-resectable, Hepatocellular Carcinoma Recurrent Trial in El Segundo (biological, drug, procedure)

Withdrawn
  • Hepatocellular Carcinoma Non-resectable
  • Hepatocellular Carcinoma Recurrent
  • ETBX-011
  • +17 more
  • El Segundo, California
    Chan Soon-Shiong Institute for Medicine
Mar 17, 2021

Chordoma, Unresectable Malignant Tumor Trial in El Segundo (biological, drug, radiation)

Withdrawn
  • Chordoma
  • Unresectable Malignant Neoplasm
  • Aldoxorubicin Hydrochloride
  • +9 more
  • El Segundo, California
    Chan Soon-Shiong Institute for Medicine
Mar 17, 2021

Urothelial Carcinoma Trial (biological, drug, radiation)

Withdrawn
  • Urothelial Carcinoma
  • avelumab
  • +19 more
  • (no location specified)
Mar 17, 2021

NSCLC Trial (biological, drug, radiation)

Withdrawn
  • Non-small Cell Lung Cancer
  • avelumab
  • +21 more
  • (no location specified)
Mar 17, 2021

Merkel Cell Carcinoma Trial (biological, drug, radiation)

Withdrawn
  • Merkel Cell Carcinoma
  • Avelumab
  • +14 more
  • (no location specified)
Mar 17, 2021

Head and Neck Squamous Cell Carcinoma Trial (biological, drug, radiation)

Withdrawn
  • Head and Neck Squamous Cell Carcinoma
  • Avelumab
  • +21 more
  • (no location specified)
Mar 17, 2021

Tumors, Prostate Cancer, Lung Cancer Trial run by the NCI (ETBX-051; adenoviral brachyury vaccine, ETBX-061; adenoviral Mucin-1

Completed
Has Results
  • Neoplasms
  • +4 more
  • ETBX-051; adenoviral brachyury vaccine
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 25, 2020

Squamous Cell Carcinoma Trial in El Segundo (drug, biological, procedure)

Unknown status
  • Squamous Cell Carcinoma
  • Aldoxorubicin HCl
  • +20 more
  • El Segundo, California
    Chan Soon-Shiong Institute for Medicine
Aug 10, 2020

Pancreatic Cancer Trial in El Segundo (drug, biological, procedure)

Unknown status
  • Pancreatic Cancer
  • Aldoxorubicin HCl
  • +18 more
  • El Segundo, California
    Chan Soon-Shiong Institute for Medicine
Jul 14, 2019

Head Neck Cancer, Head and Neck Tumors Trial run by the NCI (M7824, N803, TriAd vaccine)

Active, not recruiting
  • Head and Neck Cancer
  • Head and Neck Neoplasms
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 26, 2023

Healthy Trial in Seoul (CKR-051 Dose 1, CKR-051 Dose 2, CKR-051 Dose 3)

Not yet recruiting
  • Healthy
  • CKR-051 Dose 1
  • +4 more
  • (no location specified)
Apr 18, 2023

Influenza Prophylaxis Trial in London (INNA-051, Placebo)

Recruiting
  • Influenza Prophylaxis
  • London, United Kingdom
    hVIVO
Apr 7, 2022

COVID-19 Pandemic Trial (INNA-051, Placebo)

Withdrawn
  • COVID-19 Pandemic
  • (no location specified)
Apr 7, 2022

Tenosynovial Giant Cell Tumor, Pigmented Villonodular Synovitis Trial in Worldwide (AMB-05X)

Active, not recruiting
  • Tenosynovial Giant Cell Tumor
  • Pigmented Villonodular Synovitis
  • AMB-05X
  • Columbus, Ohio
  • +5 more
Oct 5, 2022

Melanoma, Lymphoma, Solid Tumor Trial in Worldwide (Pembrolizumab)

Recruiting
  • Melanoma
  • +4 more
  • Pembrolizumab
  • Aurora, Colorado
  • +18 more
Jan 5, 2023